Actualités réglementaires
31 août 2026•1 min de lecture
FDA Approves ANDA077655 for VALACYCLOVIR HYDROCHLORIDE Tablets
FDA has approved ANDA077655 for valacyclovir hydrochloride oral tablets (500 mg and 1 g) from Teva Pharm, with original and supplemental labeling approvals.
Actualités réglementaires
24 août 2026•1 min de lecture
FDA Approves ANDA078070 for Valacyclovir Hydrochloride Tablets by Pharmobedient
The FDA approved application ANDA078070 submitted by Pharmobedient for oral valacyclovir hydrochloride tablets (500 mg and 1 g equivalents). Both products are listed as discontinued.